Stamoulis Christiana 4

What Happened
Christiana Stamoulis, a director of Hologic, Inc. (HOLX), received a grant of 3,190 restricted stock units (RSUs) on February 26, 2026. The filing reports the award (transaction code A) with no purchase price disclosed; these RSUs will be settled one-for-one in common shares when they vest on the date of the 2027 Annual Meeting of Stockholders. Awards are a grant rather than an open-market purchase or sale and do not by themselves indicate immediate buying or selling of shares.

Key Details

• Transaction date: 2026-02-26; Form 4 filed: 2026-03-02 (filed within the standard two-business-day window).
• Award: 3,190 restricted stock units (price: N/A).
• Vesting/settlement: RSUs vest on the date of the 2027 Annual Meeting and are settled one-for-one in common stock (Footnotes F1, F2).
• Shares owned after transaction: not specified in the filing.
• Transaction code: A (award/grant). No 10b5-1, tax withholding, or sale reported in this Form 4.

Context
RSU grants are common compensation for directors and typically vest over time; they increase potential future share ownership but are not an immediate cash purchase. Because these units convert to shares on vesting, they dilute existing shareholders marginally when settled. This filing is informational and does not by itself indicate the insider’s trading sentiment.